Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroji Iwata

Showing results (1-10 of 416) with videos related to

Pageof 42
Sort By:
Breast Cancer (Tokyo, Japan)|May 9, 2007
Perspective of trastuzumab treatmentHiroji Iwata
Breast Cancer (Tokyo, Japan)|April 15, 2011
Future treatment strategies for metastatic breast cancer: curable or incurable?Hiroji Iwata
Breast Cancer (Tokyo, Japan)|July 18, 2009
Neo(adjuvant) trastuzumab treatment: current perspectivesHiroji Iwata
Breast Cancer (Tokyo, Japan)|February 3, 2018
Clinical development of CDK4/6 inhibitor for breast cancerHiroji Iwata
Breast Cancer (Tokyo, Japan)|December 9, 2010
Neoadjuvant endocrine therapy for postmenopausal patients with hormone receptor-positive early breast cancer: a new conceptHiroji Iwata
Japanese Journal of Clinical Oncology|November 15, 2011
The transition of breast cancer treatment and Japan Clinical Oncology Group research over two decadesHiroji Iwata
Chinese Clinical Oncology|June 5, 2018
Advances in treatment and care in metastatic breast cancer (MBC): are there MBC patients who are curable?Masaya Hattori, Hiroji Iwata
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 8, 2007
[Current situation and features of chemotherapy for breast neoplasms]Toshinari Yamashita, Hiroji Iwata
Japanese Journal of Clinical Oncology|March 24, 2017
Significance of primary lesion resection in Stage IV breast cancerTadahiko Shien, Hiroji Iwata
Japanese Journal of Clinical Oncology|May 10, 2017
Current approach and future perspective for ductal carcinoma in situ of the breastChizuko Kanbayashi, Hiroji Iwata
Pageof 42

Showing results (1-10 of 416) with videos related to

Sort By:
Pageof 42
Breast Cancer (Tokyo, Japan)|May 9, 2007
Perspective of trastuzumab treatmentHiroji Iwata
Breast Cancer (Tokyo, Japan)|April 15, 2011
Future treatment strategies for metastatic breast cancer: curable or incurable?Hiroji Iwata
Breast Cancer (Tokyo, Japan)|July 18, 2009
Neo(adjuvant) trastuzumab treatment: current perspectivesHiroji Iwata
Breast Cancer (Tokyo, Japan)|February 3, 2018
Clinical development of CDK4/6 inhibitor for breast cancerHiroji Iwata
Breast Cancer (Tokyo, Japan)|December 9, 2010
Neoadjuvant endocrine therapy for postmenopausal patients with hormone receptor-positive early breast cancer: a new conceptHiroji Iwata
Japanese Journal of Clinical Oncology|November 15, 2011
The transition of breast cancer treatment and Japan Clinical Oncology Group research over two decadesHiroji Iwata
Chinese Clinical Oncology|June 5, 2018
Advances in treatment and care in metastatic breast cancer (MBC): are there MBC patients who are curable?Masaya Hattori, Hiroji Iwata
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 8, 2007
[Current situation and features of chemotherapy for breast neoplasms]Toshinari Yamashita, Hiroji Iwata
Japanese Journal of Clinical Oncology|March 24, 2017
Significance of primary lesion resection in Stage IV breast cancerTadahiko Shien, Hiroji Iwata
Japanese Journal of Clinical Oncology|May 10, 2017
Current approach and future perspective for ductal carcinoma in situ of the breastChizuko Kanbayashi, Hiroji Iwata
Pageof 42